Delivery Order SPE2DB24D2101-SPE2DB25FKNFK
- Not listed
- The Defense Logistics Agency awarded a $8.3K delivery order to AmerisourceBergen Drug Corp for 60 grams of Opzelura 1.5% cream on August 4, 2025, with completion targeted for August 5, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare...
- The Defense Logistics Agency awarded a $6,139.48 delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Opzelura 1.5% cream in 60-gram units. This is a firm fixed price, non-set-aside contract with a completion date of September 16, 2025, and performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a Delivery Order (4568090195) to AmerisourceBergen Drug Corp on April 30, 2025, for the supply of Opzelura 1.5% Cream in 60-gram units. This competitively awarded, non-set-aside contract carries a ceiling value of $1,480.01 under firm fixed pricing terms, with performance to be completed by May 1, 2025, at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency awarded a $51,004.13 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Opzelura 1.5% cream (60 grams). This is a non-set-aside contract with an ultimate completion date of August 21, 2025, and represents a delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $3,358.40 to AmerisourceBergen Drug Corp for Opzelura 1.5% Cream (60 grams) on August 8, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order is non-competitive and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999. The product will be performed at AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Opzelura 1.5% Cream in a 60-gram format, with a ceiling value of $2,046.89. This competitively awarded, firm fixed-price contract is classified as a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The delivery order carries...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Opzelura 1.5% Cream in a 60-gram quantity, valued at $5,766.81. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitive award. The order is scheduled for completion by August 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child order under a larger contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $3,799.47 on June 27, 2025, for the supply of Opzelura 1.5% Cream (60gm), a pharmaceutical product with a completion date of June 30, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and...
- The Defense Logistics Agency awarded a delivery order valued at $23,093.68 to AmerisourceBergen Drug Corp for Opzelura 1.5% Cream in 60-gram units on September 25, 2025, with a completion date of September 26, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider,...
- The Defense Logistics Agency awarded a $1,513.53 delivery order to AmerisourceBergen Drug Corp on June 20, 2025, for the supply of Opzelura 1.5% cream in 60-gram quantities. This firm fixed-price contract, which is not set-aside for any specific business category, is scheduled for completion by June 23, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger...
- SPE2DB24D2101Indefinite Delivery Contract
- SPE2DB24D2101-SPE2DB25FKNFKDelivery Order
The Defense Logistics Agency awarded a $3,055.61 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Opzelura 1.5% cream (60gm) on August 7, 2025, with completion scheduled for August 8, 2025. This non-set-aside contract represents a small-value pharmaceutical procurement supporting federal medical supply needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for military and veteran healthcare systems through its extensive portfolio of medical product deliveries to the Defense Logistics Agency and its Medical Supply Chain. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.999 billion through December 2026. This prime indefinite delivery vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies globally to support military healthcare programs, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains. The contract supports critical customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 8/7/25 |